Hyderabad: Recent scientific studies have underscored the urgent need for effective monitoring of antibiotic treatments, especially in countries like India, where antibiotic misuse poses significant threats to public health.
According to a 2019 survey by the University of Washington, India witnessed a staggering 297,000 deaths due to antimicrobial resistance, surpassing fatalities from neoplasms, respiratory infections, and tuberculosis combined. This alarming statistic calls for immediate action to address the growing concern of antibiotic resistance.
In response to this pressing issue, the research and development team at BioCheck/DRG, a leading biotechnology firm based in the USA, is spearheading the development of advanced monitoring devices tailored to antibiotic therapeutic drug monitoring. Laharika Katamoni, a research scientist at BioCheck, emphasizes the firm's dedication to developing such advanced monitoring devices. "In combating antibiotic resistance, every dose is crucial, and our focus is on creating innovative solutions to monitor antibiotic treatments effectively by tracking down the dosage levels" Laharika stated. "With these advanced monitoring devices, we aim to customize dosages to combat resistance and improve healthcare outcomes across the world."
The research team at BioCheck/DRG aims to address the root causes of antibiotic resistance, with a specific focus on providing real-time insights into medication adherence and optimizing dosing strategies. “By empowering healthcare providers with these tools, we envision a future where antibiotic resistance is effectively managed, leading to significantly improved patient outcomes," Laharika stated.
The 2016 studies by CDD-US and Apollo Research Foundation, published in PLOS Medicine, underscore antibiotic resistance as a grave global threat, notably accentuated in India due to poor public health systems, hospital infections, cheap antibiotics, and rising incomes, resulting in a rise in untreatable neonatal sepsis and healthcare-associated infections, emphasizing the critical need for proactive measures. Laharika and their research team at BioCheck seek to address these challenges head-on by providing practical solutions that can be implemented worldwide. Through their dedication to combating antibiotic resistance, BioCheck aims to contribute to a healthier future for all. Laharika's vision emphasizes the importance of collaborative efforts between researchers and healthcare providers to overcome healthcare challenges in India and beyond.
As Laharika aptly puts it, "By harnessing the power of technology and research, we can overcome the healthcare obstacles facing our nation and pave the way for a brighter and healthier future." In conclusion, Laharika and their research team's visionary approach to healthcare challenges offers hope in the ongoing battle against antibiotic resistance. Through innovative research, Laharika and her team at BioCheck are working tirelessly to make a meaningful impact on healthcare outcomes in India and around the world.
